EUVIMEDEUVIMED entdecken
Multizentrische Studie

Efficacy and safety of neoadjuvant chemohormonal therapy for high-risk prostate cancer treated with robot-assisted laparoscopic radical prostatectomy: a propensity score-matched analysis (the MSUG94 group)

Yuki Yokoyama, Makoto Kawase, Shin Ebara, Tomoyuki Tatenuma, Takeshi Sasaki, Yoshinori Ikehata, Akinori Nakayama, Masahiro Toide, Tatsuaki Yoneda, Kazushige Sakaguchi, Jun Teishima, Kazuhide Makiyama und 6 weitere

International Urology and Nephrology · 2024

DOI: 10.1007/s11255-024-04268-2 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Urology and Nephrology, 2024. Verfasst von Yuki Yokoyama und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Gifu University Graduate School of Medicine, 1-1 Yanagito, Gifu, 501-1194, Japan. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostatectomy, Laparoscopy, Robotic Surgical Procedures. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsProstatectomyLaparoscopyRobotic Surgical ProceduresNeoadjuvant TherapyHumansMalePropensity ScoreRetrospective StudiesMiddle AgedAgedTreatment Outcome

Stichwörter der Autor:innen

Biochemical recurrence-free survivalHigh-risk prostate cancerLuteinizing hormone-releasing hormone antagonistNeoadjuvant chemohormonal therapyRobot-assisted laparoscopic radical prostatectomyTegafur-uracil

Autor:innen und Institutionen

  • Department of Urology, Gifu University Graduate School of Medicine, 1-1 Yanagito, Gifu, 501-1194, Japan.
  • Department of Urology, Gifu University Graduate School of Medicine, 1-1 Yanagito, Gifu, 501-1194, Japan. kawase.makoto.g5@f.gifu-u.ac.jp.
  • Department of Urology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
  • Department of Urology, Yokohama City University, Yokohama, Japan.
  • Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Tsu, Japan.
  • Department of Urology, University of Toyama, Toyama, Japan.

Zitieren

APA

Yokoyama, Y., Kawase, M., Ebara, S., Tatenuma, T., Sasaki, T., Ikehata, Y., Nakayama, A., Toide, M., Yoneda, T., Sakaguchi, K., Teishima, J., Makiyama, K., Inoue, T., Kitamura, H., Saito, K., Koga, F., Urakami, S., & Koie, T. (2024). Efficacy and safety of neoadjuvant chemohormonal therapy for high-risk prostate cancer treated with robot-assisted laparoscopic radical prostatectomy: a propensity score-matched analysis (the MSUG94 group). International Urology and Nephrology. https://doi.org/10.1007/s11255-024-04268-2

Vancouver

Yokoyama Y, Kawase M, Ebara S, Tatenuma T, Sasaki T, Ikehata Y, et al. Efficacy and safety of neoadjuvant chemohormonal therapy for high-risk prostate cancer treated with robot-assisted laparoscopic radical prostatectomy: a propensity score-matched analysis (the MSUG94 group). International Urology and Nephrology. 2024. doi:10.1007/s11255-024-04268-2

BibTeX
@article{Yokoyama2024,
  author = {Yokoyama, Yuki and Kawase, Makoto and Ebara, Shin and Tatenuma, Tomoyuki and Sasaki, Takeshi and Ikehata, Yoshinori and Nakayama, Akinori and Toide, Masahiro and Yoneda, Tatsuaki and Sakaguchi, Kazushige and Teishima, Jun and Makiyama, Kazuhide and Inoue, Takahiro and Kitamura, Hiroshi and Saito, Kazutaka and Koga, Fumitaka and Urakami, Shinji and Koie, Takuya},
  title = {Efficacy and safety of neoadjuvant chemohormonal therapy for high-risk prostate cancer treated with robot-assisted laparoscopic radical prostatectomy: a propensity score-matched analysis (the MSUG94 group)},
  journal = {International Urology and Nephrology},
  year = {2024},
  doi = {10.1007/s11255-024-04268-2}
}
Kostenlos starten →